Detalhe da pesquisa
1.
Key Parameters of Tumor Epitope Immunogenicity Revealed Through a Consortium Approach Improve Neoantigen Prediction.
Cell
; 183(3): 818-834.e13, 2020 10 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-33038342
2.
Impaired mitochondrial oxidative phosphorylation limits the self-renewal of T cells exposed to persistent antigen.
Nat Immunol
; 21(9): 1022-1033, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32661364
3.
Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer.
Nature
; 551(7681): 512-516, 2017 11 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-29132146
4.
Spatial and functional heterogeneities shape collective behavior of tumor-immune networks.
PLoS Comput Biol
; 11(4): e1004181, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25905470
5.
Prior anti-CTLA-4 therapy impacts molecular characteristics associated with anti-PD-1 response in advanced melanoma.
Cancer Cell
; 41(4): 791-806.e4, 2023 04 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37037616
6.
Lineage tracing reveals clonal progenitors and long-term persistence of tumor-specific T cells during immune checkpoint blockade.
Cancer Cell
; 41(4): 776-790.e7, 2023 04 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37001526
7.
Anti-GD2 CAR-NKT cells in relapsed or refractory neuroblastoma: updated phase 1 trial interim results.
Nat Med
; 29(6): 1379-1388, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37188782
8.
Bystander T cells in cancer immunology and therapy.
Nat Cancer
; 3(2): 143-155, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35228747
9.
Ipilimumab alone or in combination with nivolumab in patients with advanced melanoma who have progressed or relapsed on PD-1 blockade: clinical outcomes and translational biomarker analyses.
J Immunother Cancer
; 10(1)2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35074903
10.
TCR signal strength defines distinct mechanisms of T cell dysfunction and cancer evasion.
J Exp Med
; 219(2)2022 02 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34935874
11.
Hallmarks of Resistance to Immune-Checkpoint Inhibitors.
Cancer Immunol Res
; 10(4): 372-383, 2022 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35362046
12.
Cell-Free DNA Detection of Tumor Mutations in Heterogeneous, Localized Prostate Cancer Via Targeted, Multiregion Sequencing.
JCO Precis Oncol
; 52021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34250416
13.
Prioritization of SARS-CoV-2 epitopes using a pan-HLA and global population inference approach.
bioRxiv
; 2020 Jun 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-32511325
14.
Society for Immunotherapy of Cancer clinical and biomarkers data sharing resource document: Volume II-practical challenges.
J Immunother Cancer
; 8(2)2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33323463
15.
Society for Immunotherapy of Cancer clinical and biomarkers data sharing resource document: Volume I-conceptual challenges.
J Immunother Cancer
; 8(2)2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33127656
16.
Circulating Tumor DNA Analysis to Assess Risk of Progression after Long-term Response to PD-(L)1 Blockade in NSCLC.
Clin Cancer Res
; 26(12): 2849-2858, 2020 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32046999
17.
It Is a Capital Mistake to Theorize Who to Treat with Checkpoint Inhibitors before One Has Data.
Trends Cancer
; 5(2): 79-82, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30755306
18.
Tumor Characteristics Associated with Benefit from Pembrolizumab in Advanced Non-Small Cell Lung Cancer.
Clin Cancer Res
; 25(16): 5061-5068, 2019 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31113840
19.
Clonal replacement of tumor-specific T cells following PD-1 blockade.
Nat Med
; 25(8): 1251-1259, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31359002
20.
Author Correction: Anti-GD2 CAR-NKT cells in relapsed or refractory neuroblastoma: updated phase 1 trial interim results.
Nat Med
; 30(4): 1210, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38195754